Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice

BACKGROUND: Although chemopreventative agents targeting the estrogen/estrogen receptor (ER) pathway have been effective for ER(+) breast cancers, prevention of hormone receptor-negative breast cancers, such as Her2/erbB-2(+) breast cancers, remains a significant issue. Previous studies have demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zhikun, Parris, Amanda B., Xiao, Zhengzheng, Howard, Erin W., Kosanke, Stanley D., Feng, Xiaoshan, Yang, Xiaohe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217213/
https://www.ncbi.nlm.nih.gov/pubmed/28061785
http://dx.doi.org/10.1186/s13046-016-0479-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217213/
https://www.ncbi.nlm.nih.gov/pubmed/28061785
http://dx.doi.org/10.1186/s13046-016-0479-8

Ejemplares similares